1
|
Li Y, Zhang G, Mao X, Yang S, De Ruyck K, Wu Y. High sensitivity immunoassays for small molecule compounds detection – Novel noncompetitive immunoassay designs. Trends Analyt Chem 2018. [DOI: 10.1016/j.trac.2018.04.008] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
2
|
Volland H, Pradelles P, Taran F, Buscarlet L, Creminon C. Recent developments for SPIE-IA, a new sandwich immunoassay format for very small molecules. J Pharm Biomed Anal 2004; 34:737-52. [PMID: 15019052 DOI: 10.1016/s0731-7085(03)00560-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/17/2003] [Indexed: 11/18/2022]
Abstract
Recent publications describing new elegant approaches to assay small analytes using noncompetitive format were briefly reviewed. Among these methods, we have developed a new protocol, named SPIE-IA, which involves a cross-linking step achieved using chemical hombifunctional reagents, UV irradiation or free radicals. This new method proved to be useful to detect naturally occurring analyte/antibody complexes or to protect the analytes against degradation by peptidases. On the other hand, SPIE-IA could allow to study the adverse biological effects of UV and some aspects of free radical chemistry or to evaluate the antioxidant activity of molecules.
Collapse
Affiliation(s)
- Hervé Volland
- CEA, Service de Pharmacologie et d'Immunologie, DRM/DSV, CEA/Saclay, 91191 Gif-sur-Yvette Cedex, France.
| | | | | | | | | |
Collapse
|
3
|
Chabot S, Salez L, McCormack FX, Touqui L, Chignard M. Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. Am J Respir Cell Mol Biol 2003; 28:347-53. [PMID: 12594061 DOI: 10.1165/rcmb.4883] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
We previously demonstrated that resident alveolar macrophages from naive mice do not synthesize interleukin (IL)-10, whereas mononuclear phagocytes (MP) recruited during the lung inflammatory process are transiently competent for IL-10 production when exposed to lipopolysaccharide (LPS) in vitro. As surfactant protein A (SP-A), a member of the collectin family, inhibits LPS-induced in vitro IL-10 formation by bone marrow-derived macrophages, we studied its effect on MP under in vivo inflammatory conditions. When mice with LPS-induced inflamed lungs were given a second intranasal LPS administration, IL-10 concentration recovered in the bronchoalveolar lavage fluids varied as a function of the time interval between the two LPS doses. Thus, IL-10 concentration increased with the number of MP up to Day 3, and then decreased to undetectable values within 24 h, despite a continued increase in the number of MP. Analysis of IL-10 mRNA from purified MP indicated that gene expression correlated with the IL-10 level in the bronchoalveolar lavage fluid. In contrast to IL-10 production, SP-A concentrations during LPS-induced inflammation decreased with a nadir at Day 3, and then increased significantly within 24 h. Furthermore, intranasal administration of exogenous SP-A to mice with LPS-induced inflamed lungs led to a repression of the IL-10 production. In summary, this study demonstrates for the first time an in vivo inhibitory role of SP-A on the anti-inflammatory activity of MP, through inhibition of IL-10 production.
Collapse
Affiliation(s)
- Sophie Chabot
- Unité de Défense Innée et Inflammation, Unité Associée Institut Pasteur/Institut National de la Santé et de la Recherche Médicale, U485, Paris, France
| | | | | | | | | |
Collapse
|
4
|
Dias S, Jovic F, Renard PY, Taran F, Créminon C, Mioskowski C, Grassi J. Immunologically driven chemical engineering of antibodies for catalytic activity. J Immunol Methods 2002; 269:81-98. [PMID: 12379354 DOI: 10.1016/s0022-1759(02)00226-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
We describe a new strategy for the preparation of catalytic antibodies based on a two-step procedure. Firstly, monoclonal antibodies are selected only if displaying the following binding features: binding both the substrate and a reactive group in such a way that the two groups are in a reactive position towards each other. Secondly, the selected monoclonal antibodies (mAbs) are chemically engineered by covalently binding the reactive group into the binding pocket of the antibody. Using previously isolated monoclonal antibodies, we have focused our studies on the control of this second step.
Collapse
Affiliation(s)
- Sonia Dias
- Service de Pharmacologie et d'Immunologie, DRM/DSV CEA Saclay, 91191 Gif sur Yvette cedex, France
| | | | | | | | | | | | | |
Collapse
|
5
|
Kobayashi N, Goto J. Noncompetitive immunoassays for small molecules with high sensitivity and specificity. Adv Clin Chem 2002; 36:139-70. [PMID: 11605257 DOI: 10.1016/s0065-2423(01)36027-4] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Affiliation(s)
- N Kobayashi
- Graduate School of Pharmaceutical Sciences, Tohoku University, Aobayama, Aoba-ku, Sendai, Japan
| | | |
Collapse
|
6
|
Salez L, Balloy V, van Rooijen N, Lebastard M, Touqui L, McCormack FX, Chignard M. Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 2001; 166:6376-82. [PMID: 11342662 DOI: 10.4049/jimmunol.166.10.6376] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Upon LPS exposure, mononuclear phagocytes produce TNF-alpha and IL-10, two cytokines with pro- and anti-inflammatory activities, respectively. We previously described that murine resident alveolar macrophages, which play a central role in the immunosurveillance of the lung alveoli, do not synthesize IL-10 in vivo or in vitro when exposed to LPS. In the present report we demonstrate that during lung inflammation induced by the intranasal administration of LPS, bronchoalveolar cells collected between days 3 and 5 are able to synthesize IL-10 when exposed to LPS. We also show that depletion of resident alveolar macrophages by an intratracheal instillation of liposome-encapsulated clodronate is followed by subsequent replenishment of the airspaces by mononuclear phagocytes. This is accompanied by the transient competence of cells for IL-10 production. The cell capacity to produce IL-10 is evident up to 3 days and then decreases. This led us to hypothesize that the alveolar environment contains a down-regulator of LPS-induced IL-10 synthesis by recently emigrating mononuclear phagocytes. We show that the surfactant protein A, an airspace protein that has known immunomodulatory activities, dramatically inhibits LPS-induced IL-10 formation by bone marrow-derived macrophages. These data show a difference between resident and inflammatory macrophages with respect to IL-10 synthesis. Moreover, this study highlights for the first time the inhibitory role of surfactant protein A in the anti-inflammatory activity of macrophages through inhibition of IL-10 production.
Collapse
Affiliation(s)
- L Salez
- Unité de Pharmacologie Cellulaire, Unité Associée Institut Pasteur/Institut National de la Santé et de la Recherche Médicale, Paris, France
| | | | | | | | | | | | | |
Collapse
|
7
|
Buscarlet L, Volland H, Dupret-Carruel J, Jolivet M, Grassi J, Créminon C, Taran F, Pradelles P. Use of Free Radical Chemistry in an Immunometric Assay for 17β-Estradiol. Clin Chem 2001. [DOI: 10.1093/clinchem/47.1.102] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
AbstractBackground: We wished to develop an enzyme immunometric assay for 17β-estradiol (E2) in human serum using solid-phase immobilized epitope immunoassay (SPIE-IA) technology and free radical chemistry.Methods: We used an anti-estradiol monoclonal antibody as capture antibody and Fenton-like reagents to cross-link it to E2. The same antibody, labeled with acetylcholinesterase, was used for detection. Serum was diluted 10-fold before assay.Results: After correction by the dilution factor, the detection limit was 5 ng/L for human serum and intra- and interassay CVs were <7% and 15%, respectively, at concentrations of 169-2845 ng/L. No cross-reactivity was seen with other natural steroids. In comparison with a competitive commercial RIA performed on 88 undiluted human sera, the slope (SD) of the regression line was 1.05 (± 0.02) and the intercept was 47 (±27) ng/L (Sy|x = 186 ng/L) at concentrations of 20–5000 ng/L (r2 = 0.97).Conclusions: The use of Fenton-like chemistry in SPIE-IA technology allows a sensitive measurement of E2 in human serum and could be a new approach for the development of sensitive immunoassays.
Collapse
Affiliation(s)
- Laure Buscarlet
- CEA, Laboratoire d’Etudes Radioimmunologiques, SPI/DRM/DSV, and
| | - Hervé Volland
- SPI-BIO, 2 rue du Buisson aux Fraises, ZI de la Bonde, 91741 Massy Cedex, France
| | | | - Michel Jolivet
- bioMérieux, Département Immunoassays, Chemin de l’Orme, 69280 Marcy-l’Etoile, France
| | - Jacques Grassi
- CEA, Laboratoire d’Etudes Radioimmunologiques, SPI/DRM/DSV, and
| | | | - Frédéric Taran
- Service des Molécules Marquées, DBCM/DSV, CEA/Saclay, 91191 Gif-sur-Yvette Cedex, France
| | | |
Collapse
|
8
|
Volland H, Pradelles P, Ronco P, Azizi M, Simon D, Créminon C, Grassi J. A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma. J Immunol Methods 1999; 228:37-47. [PMID: 10556541 DOI: 10.1016/s0022-1759(99)00097-6] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We have developed a new enzyme immunometric assay for angiotensin II (AII) based on SPIE-IA technology (solid-phase immobilized epitope-immunoassay). A monoclonal antibody with optimal properties (mAb3 131) was selected from a series of 19 anti-AII mAbs. The mAb had to be purified from ascitic fluid in a specific manner in order to remove endogenous AII from the antibody-binding sites. We established a sensitive (minimum detectable concentration 0.5 pg/ml) and precise (CV below 15% in the 2-100 pg/ml range) SPIE-IA. Using different AII-related peptides, we observed that this new assay has a specificity profile that compares favourably with the corresponding competitive immunoassay. We have used the assay to measure AII in 42 plasma samples, and demonstrated a good correlation with values obtained using a commercial radioimmunoassay. Assay specificity was supported by HPLC fractionation experiments, confirming the absence of interference induced by endogenous AII-related products.
Collapse
Affiliation(s)
- H Volland
- SPI-BIO, 2 rue du Buisson aux Fraises, Z.I. de la Bonde, F-91741 Massy Cedex, France
| | | | | | | | | | | | | |
Collapse
|
9
|
Synthesis of haptens for the development of a solid-phase immobilized epitope-immunoassay (SPIE-IA) of AZT-TP. Tetrahedron Lett 1999. [DOI: 10.1016/s0040-4039(99)00785-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
10
|
Buscarlet L, Grassi J, Créminon C, Pradelles P, Dupret-Carruel J, Jolivet M, Mons S. Cross-linking of 17 beta-estradiol to monoclonal antibodies by direct UV irradiation: application to an enzyme immunometric assay. Anal Chem 1999; 71:1002-8. [PMID: 10079761 DOI: 10.1021/ac980870n] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Ultraviolet irradiation was used to cross-link 17 beta-estradiol directly to monoclonal anti-17 beta-estradiol antibodies coated on 96-well microtiter plates. Cross-linking efficiency was directly correlated with both irradiation energy and wave-length. The best results were obtained at 254 (10 J/cm2, 45-min irradiation) and 312 nm (40 J/cm2, 160-min irradiation). The irradiation fully denatured both individual molecules (i.e., 17 beta-estradiol and monoclonal anti-17 beta-estradiol antibody), but 17 beta-estradiol was at least partly protected when immunologically bound to the paratope of the antibody. Four different monoclonal anti-17 beta-estradiol antibodies yielded positive results, demonstrating that this photo-cross-linking has considerable potential. We used this original approach to develop a new enzyme immunometric assay of 17 beta-estradiol based on our previously described immunometric procedure, solid-phase immobilized epitope immunoassay, which uses chemical agents to cross-link haptens via amino groups to specific antibodies. The assay was specific (no cross-reactivity with other natural steroids), precise, and sensitive (detection limit of 38 pg/mL in human serum). It correlated well with two competitive commercial immunoassays when tested on 40 human sera.
Collapse
Affiliation(s)
- L Buscarlet
- CEA, Laboratoire d'Etudes Radioimmunologiques, SPI/DRM/DSV, CEA/Saclay, Gif-sur-Yvette, France
| | | | | | | | | | | | | |
Collapse
|